Valeris™ Launches Transformation Office to Enhance Integration and Value Delivery in Life Sciences

Valeris™ Expands Strategic Infrastructure with Launch of Transformation Office

Valeris has taken a significant step towards enhancing its operational capabilities with the announcement of its new Transformation Office. Established as a decisive move to guide and streamline integration efforts post-acquisition, the office aims to ensure that Valeris can continue to provide high-quality service while positioning itself for future growth in the life sciences sector.

The launch of the Transformation Office comes on the heels of the successful transaction between Mercalis and PharmaCord, marking a pivotal moment in Valeris's strategy. This new function will play a vital role in managing integration activities using a focused and well-structured approach. By dedicating resources to transformation efforts, Valeris aims to ensure a seamless experience for its clients, protecting the quality of service they rely on.

Rob Truckenmiller, Chief Executive Officer of Valeris, emphasized the importance of continuity and operational excellence in the company's vision. He stated, "The Transformation Office reflects how we think about value, not just in outcomes, but in how we operate. We are committed to delivering continuity for our clients, while building the infrastructure required to lead in a rapidly changing healthcare environment."

As the healthcare landscape continues to evolve due to regulatory changes and technological advancements, Valeris's proactive investment in its infrastructure is particularly noteworthy. The Transformation Office will spearhead initiatives focused not just on integration, but also on cultural alignment and strategic business planning within the organization.

Patrick Lee, the Chief Transformation Officer, added, "By decoupling integration from daily operations, we're protecting what matters most – service delivery – while giving ourselves the strategic space to think and build for the future. This represents a deliberate investment in transforming our organization, enabling us to innovate, enhance patient access solutions, and deliver sustained value to clients and patients alike."

To spearhead merger strategy, Valeris has appointed Laura Obregon as the Vice President and Head of Merger Strategy. With extensive experience in market access, pricing, and operational execution, Laura's previous leadership roles at EMD Serono provide her with a strong foundation for success in her new role. Patrick Lee is confident in Laura’s ability to convert strategic visions into actionable results, emphasizing the importance of cultivating cross-functional alignment within the company.

Valeris’s Transformation Office also includes other key leadership positions, such as Dean Dimitropoulos, Vice President and Head of Merger Integration, and Staci McArter Galloway, Vice President and Head of Culture Strategy & Integration. Their collective expertise will play a crucial role in ensuring that Valeris not only meets its operational objectives but also fosters a culture focused on collaboration and excellence.

Valeris stands as a fully integrated life sciences commercialization partner, offering a broad array of solutions across the entire healthcare value chain. The company's commitment to enhancing patient experiences is matched by its dedication to delivering innovative services. With a current portfolio that supports over 500 life sciences clients and millions of patients, Valeris continues to optimize its strategies to ensure improved access to critical medications.

In summary, the establishment of the Transformation Office represents a strategic milestone for Valeris as it embraces the future of healthcare services. The focus on effective integration while safeguarding service quality reflects the company's dedication to long-term growth and patient-centered solutions in an ever-evolving landscape. For further details, visit Valeris.